Health Catalyst (HCAT) Tops Q2 EPS by 6c

Health Catalyst (NASDAQ: HCAT) reported Q2 EPS of $0.05, $0.06 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $73.2 million versus the consensus estimate of $72.64 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Anterix Inc. (ATEX) Tops Q4 EPS by 152c
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00